SPS 2016 Program - Page 30

a platform that will accommodate the care for population health and high risk homebound groups. Taking a different approach from "Build it and they will come", MD24 GTN is using the focus group method to understand the difficulties from providers while using a telemedicine platform, and combining with the needs of patients to provide the solution for quality care. Through the network of our partners, including Independent Physician Associations, insurance plans, and healthcare systems, MD24 GTN brings in valuable benefits to the current practice. They all have exclusive networks of physicians and patients, both of whom will benefit from our robust platform. The interactive platform allows patients to experience a new way of taking care of their health at their convenience anywhere, even from home. 6. Factors that Affect Computer-assisted Diagnosis Supporting Teleretinal Consultations Jorge Cuadros, OD, PhD1,2, Carolyn Smith-Morris, PhD, MS, LPC3, Kathryn Bouskill, PhD2, George Bresnick MD, MPA1,2 1 University of California, Berkeley, 2EyePACS LLC, 3 Southern Methodist University Background: Teleretinal programs (TR) have been performed successfully on millions of patients with diabetes. Computer assisted diagnosis (CAD) has been developed for automated detection of retinal disease, and provides accurate and immediate results that can be used for triage of patients to treatment. Adherence with TR recommendations for timely treatment is low, however, and treatment is often delayed until symptoms arise and successful outcomes are much less likely. This study identifies key factors that influence patient adherence and will guide the development of new features in TR, including CAD. Methods: Two ethnographers and one computer-human interface expert along with the EyePACS research team interviewed 24 patients and 24 staff members in three clinics that use TR. The interviews focused on referral processes and adherence with treatment plans. Results: Most patients who are referred for treatment from TR are not being treated in a timely manner: 1. Substantial barriers exist in scheduling follow-up appointments from TR visits. 2. Failure to integrate TR results into Primary Care is linked with inadequate communication and support of referred patients. 3. Patient education is considered important but is not supported in the TR process. 4. Cultural, religious, and social factors greatly influence patient decisions about treatment. 5. Comorbidities also influence patient decisions about eye treatment when patients see well. 6. Social isolation is both a cause and outcome of poor health and is not addressed by TR. Conclusion: While teleretinal programs continue to grow, development must b ”™½ΥΝ•½ΈΡ…ɝ•Ρ₯ΉœΡ‘”Ι₯‘Ё₯Ή‘₯Ω₯‘Υ…±Μ…Ή•Ή‘…Ή₯Ήœ…ΉΝΥΑΑ½ΙΡ₯Ήœ™½±±½άΡ‘ɽ՝ έ₯Ρ ±₯Ω”)΅•‘₯…°…Ι”Έ ΅…δ₯΅ΑΙ½Ω”™½±±½άΡ‘ɽ՝ ₯˜₯Ё₯́‘•Ω•±½Α•₯Έ„έ…δΡ‘…ЁΝΥΑΑ½ΙΡ́ё”Ι•™•ΙΙ…°ΑΙ½•Ν́…Ή•Ή…•Μ)Α…Ρ₯•ΉΡΜΈ((άΈ9½Ω•°”΅!•…±Ρ %ΉΡ•ΙΩ•ΉΡ₯½Έ™½ΘA…Ή₯Œ)₯Ν½Ι‘•ΘθΥΉΡ₯½Ή…°%΅ΑΙ½Ω•΅•ΉΠ)…ΉA…Ρ₯•ΉΠ ½΅Α±₯…Ή”)I½‰•ΙЁ8Έ Υ展ȰA‘)A…±Ό±ΡΌ!•…±Ρ M₯•Ή•Μ) …­Ι½ΥΉθA…Ή₯Œ‘₯Ν½Ι‘•Θ₯́„½΅΅½Έ…Ή‘•‰₯±₯Ρ…Ρ₯Ήœ)½Ή‘₯Ρ₯½ΈΡ‘…ЁΑΙ½‘Ս•ΜΡ•ΙΙ₯™ε₯ΉœΝε΅ΑΡ½΅ΜΝՍ …́‘•ΝΠ)Α…₯Έ°Ν‘½ΙΡΉ•Ν́½˜‰Ι•…Ρ °™•…ȁ½˜‘ε₯Ήœ½Θ±½Ν₯Ήœ½ΉΡΙ½°Έ ½ΉΝ•ΕΥ•Ή•Μ₯Ή±Υ‘”Ν½₯…°…Ή©½ˆ₯΅Α…₯Ι΅•ΉΠ°•α•Ν́΅•‘₯…°)ΝΑ•Ή‘₯Ήœ°…Ή‘•Ω•±½Α΅•ΉΠ½˜…½Ι…Α‘½‰₯„°‘•ΑΙ•ΝΝ₯½Έ…Ή)ΝΥ‰ΝΡ…Ή”ΥΝ”‘₯Ν½Ι‘•ΙΜΈ ΥΙΙ•ΉΠ™₯ΙΝЁ±₯Ή”ΡΙ•…Ρ΅•ΉΡ́₯Ή±Υ‘”)΅•‘₯…Ρ₯½Έ…ΉΡ‘•Ι…Α䁉ΥЁ•… ‘…́Ν₯Ή₯™₯…ΉΠ±₯΅₯Ρ…Ρ₯½ΉΜΈ)QΙ•…Ρ΅•ΉΠ‘Ι½ΐ΅½ΥЁ₯́½΅΅½Έ₯Έ‰½Ρ ΈA…±Ό±ΡΌ!•…±Ρ M₯•Ή•Μ½™™•Ίё”Ι••ΝΑ₯Ι„ Ι•…Ρ‘₯ΉœMεΝΡ•΄°…Έ΅±•…Ι•)₯ΉΡ•ΙΩ•ΉΡ₯½Έ™½ΘΡΙ•…Ρ΅•ΉΠ½˜Α…Ή₯ŒΡ‘…Ёѕ…‘•Μ±₯•ΉΡ́Ѽ)΅½‘₯™δΡ‘”‘εΝ™ΥΉΡ₯½Ή…°‰Ι•…Ρ‘₯ΉœΑ…Ρѕɹ́‘…Ι…Ρ•Ι₯ΝΡ₯Œ½˜)Α…Ή₯ŒΝΥ™™•Ι•ΙΜΈQ‘”₯ΉΡ•ΙΩ•ΉΡ₯½Έ₯́…Έ”΅‘•…±Ρ ₯ΉΡ•ΙΩ•ΉΡ₯½Έ)Ρ‘…Ё₯́ΑΙ…Ρ₯•Ρέ₯”‘…₯±δ…Ё‘½΅”™½Θ½Ή”΅½ΉΡ Έ%Ή₯Ρ₯…°)±₯•ΉΠΡΙ…₯Ή₯Ήœ…Έ‰”₯Ω•Έ•₯Ρ‘•Θ₯ΈΑ•ΙΝ½Έ½ΘΩ₯„Ν•ΥΙ”Ρ•±•‘•…±Ρ Έ…Ρ„…Ι”ΥΑ±½…‘•ΡΌΡ‘”½΅Α…ΉηŠé͕ΥΙ”Ν•ΙΩ•Θ)™½±±½έ₯Ήœ•… Ν•ΝΝ₯½Έ°ΝΌΡ‘…Ё±₯•ΉΠ…‘‘•Ι•Ή”…ΉΑΙ½Ι•ΝΜ)₯́…Ω…₯±…‰±”…Ν幍‘Ι½Ή½ΥΝ±δΡΌΡ‘”±₯Ή₯₯…ΈΈ)5•Ρ‘½‘ΜθI••ΉΠ±₯Ή₯…°ΡΙ₯…±ΜΑΙ½Ω₯‘•Ι••ΝΑ₯Ι‡Šé…ΑΉ½΅•ΡΙδ΅…ΝΝ₯ΝΡ•‰Ι•…Ρ‘₯ΉœΡΙ…₯Ή₯ΉœΡΌΝΥ‰©•Ρ́έ₯Ρ Α…Ή₯Œ)‘₯Ν½Ι‘•Θ…Ή΅•…ΝΥΙ•‰…Ν•±₯Ή”…ΉΑ½ΝΠ΅ΡΙ•…Ρ΅•ΉΠ™ΥΉΡ₯½Ή₯ΉœΈQ‘₯́Α½ΝѕȁΑΙ•Ν•ΉΡ́‘₯͍½ΉΡ₯ΉΥ…Ρ₯½Έ…Ή…‘‘•Ι•Ή”‘…Ρ„)½Έ±₯Ή₯…°ΡΙ₯…±ΜΝΥ‰©•Ρ́…́ݕ±°…́™Ι½΄Ι½ΥΡ₯Ή”±₯Ή₯…°ΑΙ…Ρ₯”Έ%Έ…‘‘₯Ρ₯½Έ°„ΝՉ͕Ё½˜±₯Ή₯…°ΡΙ₯…±ΜΝΥ‰©•Ρ́͑½έ₯ΉœΡ‘”)΅½ΝЁ͕ٕɔ™ΥΉΡ₯½Ή…°₯΅Α…₯Ι΅•ΉΠέ•Ι”…ΝΝ•ΝΝ•ΥΝ₯ΉœΡ‘”)M‘••‘…Έ₯Ν…‰₯±₯ΡδM…±”Ν½Ι”…Ё‰…Ν•±₯Ή”…Ή½Ή”ε•…ȁΑ½ΝΡΡΙ•…Ρ΅•ΉΠΈ)I•ΝΥ±ΡΜθQΙ•…Ρ΅•ΉΠ‘₯͍½ΉΡ₯ΉΥ…Ρ₯½ΈΙ…ѕ́ݕɔ€Θΐ”½Θ‰•±½ά°έ‘₯±”€ΰά”½˜±₯•ΉΡ́½΅Α±•Ρ•Ρ‘”Ι•½΅΅•Ή‘•)½ΥΙΝ”½˜ΡΙ•…Ρ΅•ΉΠΈM‘••‘…Έ₯Ν…‰₯±₯ΡδM…±”Ν½Ι•ΜΝ‘½έ•)±₯Ή₯…±±δ…ΉΝΡ…Ρ₯ΝΡ₯…±±δΝ₯Ή₯™₯…ΉΠ‘•Ι•…Ν•ΜΈ) ½Ή±ΥΝ₯½ΉΜθQ‘”΅…©½Ι₯Ρ䁽˜±₯•ΉΡ́ΥΝ”Ρ‘”‘•Ω₯”…́‘₯Ι•Ρ•…Ή‘…Ω”±½άΙ…ѕ́½˜‘₯͍½ΉΡ₯ΉΥ…Ρ₯½ΈΈ‘‘₯Ρ₯½Ή…±±δ°)Ι•΅½Ρ”΅½Ή₯Ρ½Ι₯Ήœ…Α…‰₯±₯ΡδΑΙ½΅½Ρ•Μ½΅Α±₯…Ή”…Ή)‰•Ή•™₯ΠΈ…Ρ„Ι•™±•ΠΙ…Α₯…ΉΝ₯Ή₯™₯…ΉΠ‘•Ι•…Ν”₯Έ™ΥΉΡ₯½Ή…°₯΅Α…₯Ι΅•ΉΠΈQ‘”Ν₯Ή₯™₯…ΉΠΙ•‘ՍΡ₯½ΉΜ₯Έ‘₯ΝΙΥΑΡ₯½Έ½˜)έ½Ι¬½Ν‘½½°™ΥΉΡ₯½Έ°Ν½₯…°…Ρ₯Ω₯Ρ₯•Μ°…Ή™…΅₯±δ½‘½΅”)Ι•ΝΑ½ΉΝ₯‰₯±₯Ρ₯•Μ΅…δΙ•‘Ս”Ρ‘”₯΅Α…Π½˜Ρ‘₯́‘₯Ν½Ι‘•Θ½Έ)ΕΥ…±₯Ρ䁽˜±₯™”…ΉΑΙ½‘ՍΡ₯Ω₯Ρ䁅Ή‘•Ι•…Ν”΅•‘₯…°½ΝΡΜΈ((ΜΐπA…”((